Even chained acylcarnitines predict long-term cardiovascular prognosis in patients with chest pain and non-obstructive coronary artery disease.

Storesund, Silje Kjellevold; Karaji, Iman; Strand, Elin; Svardal, Asbjørn; Lønnebakken, Mai Tone; Berge, Rolf Kristian; Tveitevåg Svingen, Gard Frodahl; Nygård, Ottar Kjell; Pedersen, Eva Ringdal

Storesund, Silje Kjellevold; Karaji, Iman; Strand, Elin; Svardal, Asbjørn; Lønnebakken, Mai Tone; Berge, Rolf Kristian; Tveitevåg Svingen, Gard Frodahl; Nygård, Ottar Kjell; Pedersen, Eva Ringdal.

Afiliação

Storesund SK; Department of Heart Disease, Haukeland University Hospital, Bergen, Norway.
Karaji I; Department of Clinical Science, University of Bergen, Bergen, Norway.
Strand E; Department of Heart Disease, Haukeland University Hospital, Bergen, Norway.
Svardal A; Department of Clinical Science, University of Bergen, Bergen, Norway.
Lønnebakken MT; Department of Immunology and Transfusion Medicine, Haukeland University Hospital, Bergen, Norway.
Berge RK; Department of Clinical Science, University of Bergen, Bergen, Norway.
Tveitevåg Svingen GF; Department of Heart Disease, Haukeland University Hospital, Bergen, Norway.
Nygård OK; Department of Clinical Science, University of Bergen, Bergen, Norway.
Pedersen ER; Department of Clinical Science, University of Bergen, Bergen, Norway.

Int J Cardiol Cardiovasc Risk Prev ; 14: 200134, 2022 Sep.

Article em En | MEDLINE | ID: mdl-35647612

Palavras-chave

Acylcarnitines; Metabolism; Non-obstructive coronary artery disease; Outcomes

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Int J Cardiol Cardiovasc Risk Prev Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google